ondansetron has been researched along with Peripheral Nerve Injury in 4 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kimura, M | 2 |
| Obata, H | 2 |
| Saito, S | 1 |
| Bannister, K | 1 |
| Patel, R | 1 |
| Goncalves, L | 1 |
| Townson, L | 1 |
| Dickenson, AH | 2 |
| Hayashida, K | 1 |
| Yoshizumi, M | 1 |
| Hobo, S | 1 |
| Eisenach, JC | 1 |
| Suzuki, R | 1 |
| Rahman, W | 1 |
| Hunt, SP | 1 |
4 other studies available for ondansetron and Peripheral Nerve Injury
| Article | Year |
|---|---|
Peripheral nerve injury reduces analgesic effects of systemic morphine via spinal 5-hydroxytryptamine 3 receptors.
Topics: Analgesics, Opioid; Animals; Behavior, Animal; Immunohistochemistry; Injections, Intraperitoneal; In | 2014 |
Diffuse noxious inhibitory controls and nerve injury: restoring an imbalance between descending monoamine inhibitions and facilitations.
Topics: Action Potentials; Adrenergic alpha-2 Receptor Antagonists; Analysis of Variance; Animals; Biogenic | 2015 |
Ondansetron reverses antihypersensitivity from clonidine in rats after peripheral nerve injury: role of γ-aminobutyric acid in α2-adrenoceptor and 5-HT3 serotonin receptor analgesia.
Topics: Adrenergic alpha-2 Receptor Agonists; Analgesia; Animals; Clonidine; Disease Models, Animal; gamma-A | 2012 |
Descending facilitatory control of mechanically evoked responses is enhanced in deep dorsal horn neurones following peripheral nerve injury.
Topics: Action Potentials; Animals; Male; Neural Pathways; Ondansetron; Pain Measurement; Peripheral Nerve I | 2004 |